openPR Logo
Press release

Graft Versus Host Disease Treatment Market by Product Type, Disease Type, Distribution Channel and Geography. Key Players are Novartis, Merck, Soligenix, Mesoblast, Sanofi, Neovii Biotech, Astellas Pharma and Mallinckrodt Pharmaceuticals.

Graft Versus Host Disease Treatment Market by Product Type,

Graft versus host disease is an immune-mediated disease. It is the medical complication in which there would be a complex interaction between the donor and the adaptive immunity of the recipient. The disease occurs when the bone marrow or the stem cells are transplanted. The treatment using the stem cells and bone marrow are used in the reconstruction of the damaged cells which surround the cancer cells

Changing aspects of graft versus host disease market
Factors responsible for growth of graft versus host disease market are
• Increasing cases of cancer patients and increasing bone marrow transplantations required for various types of cancers
• Rise in count of allogeneic hematopoietic stem cell transplant
• Growing R & D activities for newer drug development process will fuel the growth of the market.

However, large amount of monetary investments for clinical trials, stringent government regulations can hinder the growth of graft versus host diseases treatment market.

Regional Analysis:
The global graft versus host disease treatment market is led by North America due to increasing cases of cancer. The increasing healthcare spending, rising counts of bone transplantations and adoption of newer technologies and modern treatment options are growing the market of graft versus host disease.

Read more Insights at https://www.precisionbusinessinsights.com/market-reports/graft-versus-host-disease-treatment-market/

Some of the key players in the global graft versus host disease treatment market include:
• Novartis AG (Switzerland)
• Merck & Co. (U.S)
• Soligenix, Inc. (U.S)
• Mesoblast Ltd (Australia)
• Sanofi (France)
• Neovii Biotech GmbH (Switzerland)
• Astellas Pharma Inc. (Japan)
• Mallinckrodt Pharmaceuticals (UK)

Notable market development:
PREVYMIS (Letermovir) of Merck & Co. received FDA approval for prevention of disease in adult allogeneic stem cell transplant patients and prevention of Cytomegalovirus (CMV) infection.

Download free sample report at https://bit.ly/2KQJSwe

The global graft versus host disease market is divided into following categories-

By product type
• Monoclonal Antibodies
• Tyrosine Kinase Inhibitors
• Thalidomide
• mTOR Inhibitors
• Others

By disease type
• Acute Graft vs. Host Disease (aGvHD)
• Chronic Graft vs. Host disease (cGvHD)

By end-users
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

By geographical regions
• North America
• Latin America
• Europe
• The Middle East & Africa
• Asia-Pacific

About Precision Business Insights
Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

Contact us
Kemp House,
152 – 160 City Road,
London EC1V 2NX
Email: sales@precisionbusinessinsights.com
Toll Free (US):+1-866-598-1553
Website @https://www.precisionbusinessinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Graft Versus Host Disease Treatment Market by Product Type, Disease Type, Distribution Channel and Geography. Key Players are Novartis, Merck, Soligenix, Mesoblast, Sanofi, Neovii Biotech, Astellas Pharma and Mallinckrodt Pharmaceuticals. here

News-ID: 1483128 • Views:

More Releases from Precision Business Insights

Home Textiles Market Growth Drivers, Trends and Regional Analysis 2024
Home Textiles Market Growth Drivers, Trends and Regional Analysis 2024
According to Precision Business Insights (PBI), the latest report, the market value of the home textiles market size was valued at USD 114.5 Billion in 2023, growing at a CAGR of 7.2% from 2024 to 2030. The main factors that drive the market are the growing home décor preferences as a result increased in home textile market, rising development of real estate, and increasing demand for home furnishing. View Full Report:
Green Ammonia Market Analysis Current Landscape and Future Outlook 2024
Green Ammonia Market Analysis Current Landscape and Future Outlook 2024
According to Precision Business Insights (PBI), the latest report, the market value of the green ammonia market size was valued at USD 382.3 million in 2023 and is projected to grow at an 29.2% CAGR during the forecast period 2024 to 2030. The main factors that drive the market are the growing awareness about renewable energy resources, decrease in natural gas availability peoples are shifting towards green energy with zero
Algae-based Feed Market Size, Growth Opportunities 2024-2030
Algae-based Feed Market Size, Growth Opportunities 2024-2030
According to Precision Business Insights' (PBI) latest report, the market value of the Algae-based Feed Market size was valued at USD 3,002.00 million in 2023 and is projected to grow at a 5.5% CAGR from 2024 to 2030. The primary factors that drive the market are the growing awareness of the nutritional benefits of algae-based feed, rising animal health consciousness, and increasing demand for high-quality and efficient nutritional feed. View Full
Pea Flakes Market Dynamics, Growth Drivers, Market Constraints and Challenges 2024
Pea Flakes Market Dynamics, Growth Drivers, Market Constraints and Challenges 20 …
According to Precision Business Insights' (PBI), latest report, the global Pea Flakes Market size was valued at USD 1,793.5 million in 2023, growing at a 12.2% CAGR during the forecast period 2024 to 2030. The primary factors that drive the market are growing health awareness across the world, rising cardiovascular and other dietary patients' need for cholesterol-free food, and increased demand for pea flakes products in the market. View Full Report:

All 5 Releases


More Releases for Graft

Graft Delivery Devices Market Facts, Figures and Analytical Insights, 2017 to 20 …
Global Graft Delivery Devices Market: Snapshot Graft delivery relates to the surgically transplantation of a piece of living tissues and the procedure can be highly essential as well as complex at the same time. Consequently, technological advancements have paved way to graft delivery devices that can minimally breach bone, fat, and vascular parts of the body to transfer drugs during plastic and reconstructive surgeries as well as arthroscopic and orthopedic surgeries.
Glass Graft Polyols Market 2019| BASF SE, Sinopec, Shell, Oltchim, The Dow Chemi …
Market Research Hub (MRH) has actively included a new research study titled “Global Graft Polyols Market” Research Report 2019 to its wide online repository. The concerned market is discoursed based on a variety of market influential factors such as drivers, opportunities and restraints. This study tends to inform the readers about the current as well as future market scenarios extending up to the period until forecast period limit; 2025. In
Global Vascular Graft Market Growth Analysis Report 2018-2025Global Vascular Gra …
Research Report 2018-2025 on "Global Vascular Graft Market" which provides an outlook of current market value of Vascular Graft Market as well as the expected forecast of Rate on Investment (ROI) with growing CAGR of XX% in Vascular Graft Market by the end of 2025. The report on the global Vascular Graft market uses the top-down and bottom-up approaches to define, analyze, and describe the Vascular Graft market 2018 trends
Vascular Graft Market Report 2018: Segmentation by Product (Endovascular Stent G …
Global Vascular Graft market research report provides company profile for W. L. Gore & Associates, Inc., C.R. Bard, Inc., MAQUET Holding B.V. & Co. KG (Getinge Group), Cook Medical, Inc., B. Braun Melsungen AG, Medtronic plc, LeMaitre Vascular, Inc., Vascutek Ltd. (Terumo Company) and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to
Innovation in Bone Graft Techniques Drives the Global Dental Membrane and Bone G …
Dental membrane and bone graft substitutes is used in the bone graft surgeries. Bone graft surgery is required when tooth is lost by accidents, dental disease and old age. According to WHO, Globally, about 30% of people aged 65–74 have no natural teeth and Across the world, 16-40% of children in the age range 6 to12 years old are affected by dental trauma due to unsafe playgrounds, unsafe schools, road
Global Bone Graft and Substitutes Market: Growing Demand for Bone Graft Substitu …
With only a few companies enjoying dominance, the global bone grafts and substitutes market demonstrates a consolidated vendor landscape. As per Transparency Market Research (TMR), the top three companies including Stryker Corporation, Zimmer, and Medtronic accounted for over 50% of the market in 2014. “The key market players are in a constant competitive state as they vie for sustainable growth and increasing their global footprint,” said a lead TMR analyst